Current location:business >>
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
business99People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b ...
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“International Infusion news portal”。http://guam.prpsystems.net/article-17d899129.html
Related articles
The unstoppable duo of Emma Stone and Yorgos Lanthimos
businessCANNES, France (AP) — Before a journalist has even lobbed a question, Emma Stone and Yorgos Lanthimo ...
【business】
Read moreChina's trade with other BRICS members up 11.3 pct in Q1
businessBEIJING, May 1 (Xinhua) -- China's trade with other BRICS members hit 1.49 trillion yuan (about 209. ...
【business】
Read moreKyren Wilson wins world snooker championship for the first time after beating Jak Jones 18
businessSHEFFIELD, England (AP) — English player Kyren Wilson won the world snooker championship for the fir ...
【business】
Read more
Popular articles
- Student fatally shot, suspect detained at Georgia's Kennesaw State University
- Dylan Cease says last year with White Sox 'wasn't enjoyable in really any way'
- Revealed: The '18 DEMANDS' Muslim Vote group issued to Keir Starmer after dozens of pro
- A US company is fined $650,000 for illegally hiring children to clean meat processing plants
- The fightback begins: Boss of London's Queen Mary University tells pro
- White Sox recall Mike Clevinger from Triple
Latest articles
Trump accepts a VP debate but wants it on Fox News. Harris has already said yes to CBS
Dodgers place Kelly on injured list. Buehler activated to make first start in 2 years
Analysis: Lando Norris win shows McLaren is ready to return to global motorsports prominence
Dylan Cease says last year with White Sox 'wasn't enjoyable in really any way'
OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Wisconsin judge dismisses lawsuit challenging state's new wolf management plan
LINKS
- Tāngarākau campground murder: Justice Williamson
- Unlicensed Hastings driver toppled motorcyclist, drove over him, causing fatal injuries, then fled
- Foreign Affairs Minister Winston Peters to resume 'Pacific reset' plan again
- China gives monks a list of things they can’t do after the Dalai Lama's death — Radio Free Asia
- Doggy ballgowns, surveillance tech and cloning services for sale at China pet fair
- Robert Kennedy Jr apologises to family over Super Bowl ad
- Pioneering observation satellite ERS
- Firefighters battle large bush fire in the Far North
- Watch: Peru policeman dressed as bear pounces on Valentine’s Day
- Chlöe Swarbrick announces she will run for Greens co